IP Verse

Maiwald competitive analysis

Loading summary...

Explore patent oppositions filed by Maiwald against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP3947723	Methods And Compositions For Analyzing Nucleic Acid	CLARET BIOSCIENCE	Sep 18, 2025
EP3509637	Methods Of Using A Bispecific Antibody That Recognizes Coagulation Factor Ix And/Or Activated Coagulation Factor Ix And Coagulation Factor X And/Or Activated Coagulation Factor X	CHUGAI SEIYAKU KABUSHIKI KAISHA	Aug 26, 2025
EP3832526	Positioning And Identification Of Electronic Labels Using A Camera	PRICER	Aug 22, 2025
EP4108671	Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof	MODERNA	Aug 20, 2025
EP3242666	Methods Of Treating Conditions Related To The S1P1 Receptor	ARENA PHARMACEUTICALS	Jul 15, 2025
EP3496551	Liquid Allulose Composition	PFEIFER & LANGEN	Jul 2, 2025
EP3853305	High-Purity Peg Lipids And Uses Thereof	MODERNA	Jul 2, 2025
EP4125903	Methods For Dose Initiation Of Aripiprazole Treatments	OTSUKA PHARMACEUTICAL	Jul 1, 2025
EP3885480	Filtration Material Using Fiber Blends That Contain Strategically Shaped Fibers And/Or Charge Control Agents	MATIV LUXEMBOURG	Jun 11, 2025
EP4129270	Modified Release Orally Administered Amino Acid Formulations	APR APPLIED PHARMA RESEARCH	Jun 10, 2025

Explore the latest publications and patents granted to Maiwald, showcasing their recent innovations and technological advancements.

Discover the latest PTAB cases involving Maiwald, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Maiwald with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
MAIWALD	136	-	-	-
F HOFFMANN LA ROCHE	16	140	-	-
MODERNA	5	75	4	2
NOVARTIS	6	422	-	21